Amplification of MYCN and AURKA (Aurora Kinase A) genes has also been observed in NEPC, with amplification of both genes seen in approximately 40% of NEPC cases and 5% of adenocarcinoma tumors [32]. This evidence concerns the gene AURKA and adenocarcinoma.